| 标题 |
 475TiP ARTEMIDE-HCC01: A phase III, randomised, open-label, sponsor-blinded, multicentre, global study of rilvegostomig in combination with bevacizumab with or without tremelimumab as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of Oncology 作者：J. Zhou; S.L. Chan; L. Goyal; N. Ben Khaled; M. Kudo; et al 出版日期：2025-12-23 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Kao
cdercder
Criminology34
Nole
伶俐妙海
Copyright
yjh123
OK
sagitar
学术文献互助
蓝天
GingerF
初景
老胡
avalanche
aaaa
愉快的真
追寻向彤
潇洒的惋清
皖公网安备34019202002308
